Showing results (1101-1110 of 1,526) with videos related to

Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|May 1, 2026
Autosomal Dominant Tubulointerstitial Kidney Disease Clinical Trial Simulator: Case Reports of Model-Informed Drug DevelopmentShyam S Ramesh, Mark Rogge, Jongjin Kim, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 7, 2026
Assessing Covariate Clinical Relevance in High-Dimensional PK Analysis: A Comparison of SCM+, FFEM, and FREM ApproachesMorgane Philipp, Sylvie Retout, Simon Buatois, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 17, 2026
PK and PK/PD Modeling of Bcl2 Inhibitor S65487 in Patients With AML and Investigation of Nonlinearity With MicrodosingChloé Burlot, François Riglet, Mathilde Romagnoli, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 19, 2026
Polymyxin B Intravenous Administration Strategy Guided by Minimum Inhibitory Concentration in Critically Ill Patients With Pulmonary Infection: Insights From PBPK ModelingShengnan Zhang, Nan Yang, Ruwei Yang, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 24, 2026
Automated Pharmacometric Model Development by Leveraging Low-Dimensional Neural ODEs and LASSO RegressionDominic Stefan Bräm, Bernhard Steiert, Britta Steffens, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 6, 2026
Modeling Peak Expiratory Flow in Patients With Asthma and Quantifying Treatment Effects Using a Mixed-Effects Hidden Markov ModelLudvig Jakobsson, Marcus Baaz, Jacob Leander, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 4, 2026
Simulation Framework to Investigate Efficacy and Ocular Safety of Belantamab Mafodotin Combinations in Relapsed/Refractory Multiple MyelomaFernando Carreño, Martijn van Noort, Adekemi Taylor, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 21, 2026
Development of the Weight-Tiered Q3W Regimen of Amivantamab in Combination With Carboplatin-Pemetrexed in EGFR-Mutated Non-Small Cell Lung CancerDongfen Yuan, Corey J Bishop, Jaydeep Mehta, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 27, 2021
Quantitative modeling predicts competitive advantages of a next generation anti-NKG2A monoclonal antibody over monalizumab for the treatment of cancerPhillip Spinosa, Monika Musial-Siwek, Marc Presler, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 21, 2026
Using Stochastic Simulation-Estimation and Automated Model Development to Assess Power and Accuracy for Covariate IdentificationYa-Han Hsu, Bárbara Costa, Nuno Vale, et al.
Pageof 153